AMP-activated protein kinase (AMPK) alpha-1/beta-1/gamma-1 · PROTEIN COMPLEX · Homo sapiens
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Move to another high-traffic target or paste a specific ChEMBL target ID.
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-13Protein identity stays anchored to UniProt P54619. Use UniProt P54619 as the stable identity anchor, then attach disease evidence before program review.
Use UniProt P54619 as the stable identity anchor, then attach disease evidence before program review.
5'-AMP-activated protein kinase subunit gamma-1
Review this target as AMP-activated protein kinase (AMPK) alpha-1/beta-1/gamma-1, mapped to UniProt P54619. ChEMBL maps the protein component as 5'-AMP-activated protein kinase subunit gamma-1. Sequence length is 331 aa.
Protein source · UniProt accession via ChEMBL component mappingKeep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats AMP-activated protein kinase (AMPK) alpha-1/beta-1/gamma-1 as ChEMBL target CHEMBL2111345, mapped to UniProt P54619. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether AMP-activated protein kinase (AMPK) alpha-1/beta-1/gamma-1 is the right protein anchor across sources, using UniProt P54619 as the stable mapping.
Jump to Protein ContextUse this block first when you need the strongest disease program and evidence level in one place.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardVerify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | AMP-activated protein kinase (AMPK) alpha-1/beta-1/gamma-1 |
| Target Type | PROTEIN COMPLEX |
| Organism | Homo sapiens |
| UniProt | P54619 |
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | 5'-AMP-activated protein kinase subunit gamma-1 |
| UniProt Accession | P54619 |
| Component Type | Protein |
| Sequence Length | 331 aa |
5'-AMP-activated protein kinase subunit gamma-1
Review this target as AMP-activated protein kinase (AMPK) alpha-1/beta-1/gamma-1, mapped to UniProt P54619. ChEMBL maps the protein component as 5'-AMP-activated protein kinase subunit gamma-1. Sequence length is 331 aa.
| ChEMBL ID | pChEMBL | Type | Value (nM) | Phase |
|---|---|---|---|---|
| CHEMBL6048763 | 10.3 | EC50 | 0.05 | Preclinical |
| CHEMBL5810593 | 10.05 | EC50 | 0.09 | Preclinical |
| CHEMBL5836835 | 10.0 | EC50 | 0.1 | Preclinical |
| CHEMBL5892252 | 9.82 | EC50 | 0.15 | Preclinical |
| CHEMBL5771550 | 9.64 | EC50 | 0.23 | Preclinical |
| CHEMBL5796255 | 9.43 | EC50 | 0.37 | Preclinical |
| CHEMBL6009640 | 9.4 | EC50 | 0.4 | Preclinical |
| CHEMBL5783632 | 9.34 | EC50 | 0.46 | Preclinical |
| CHEMBL5891901 | 9.3 | EC50 | 0.5 | Preclinical |
| CHEMBL6032116 | 9.26 | EC50 | 0.55 | Preclinical |
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| protein complex format | 94 | 113 | 7.8 |
| cell-based format | 26 | 19 | 7.3 |
| assay format | 13 | 13 | 7.4 |